Overlap of gastrointestional symptom complexes in a US community

Neurogastroenterology and Motility

Volumn 17, Issue 1, 2005, Pages 29-34

  Locke III, G Richard ^a,b   Zinsmeister, A R ^a   Fett, S L ^a   Melton III, L J ^a   Talley, N J ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Constipation; Diarrhoea; Dyspepsia; Epidemiology; IBS; Reflux

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONSTIPATION; DIARRHEA; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SELF REPORT; UNITED STATES; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; GASTROINTESTINAL DISEASE; INFORMATION PROCESSING; LONGITUDINAL STUDY; MIDDLE AGED; STATISTICAL ANALYSIS;

ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; UNITED STATES;

EID: 13444269490     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2004.00581.x     Document Type: Article

References (21)

1. Locke GR. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996; 25: 1-19.
2. Locke GR, Zinsmeister AR, Talley N, Fett SL, Melton LJ III. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000; 75: 907-12.
3. Drossman DA, Li Z, Andruzzi E et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
4. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000; 95: 1439-47.
5. Fischler B, Tack J, De Gucht V et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 903-10.
6. Whitehead WE, Cook EW III, Taub E. Factor analysis of gastrointestinal symptoms. Gastroenterology 1996; 110: 969-70.
7. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000; 355: 1035-40.
8. Muller-Lissner SA, Fumagalli I, Bardhan KD et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 1655-66.
9. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002; 37: 917-23.
10. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. 2): 1137-42.
11. Stanghellini V, Tosetti C, Paternico A et al. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999; 94: 2080-5.
12. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783-8.
13. Cuomo R, Sarnelli G, Grasso R et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol 2001; 36: 1030-6.
14. Tjeerdsma HC, Smout AJ, Akkermans LM. Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 1993; 38: 832-6.
15. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
16. Talley N, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire (special article). Mayo Clin Proc 1990; 65: 1456-79.
17. Attanasio V, Andrasik F, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist. J Behav Med 1984; 7: 247-258.
18. Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000; 95: 157-65.
19. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G, Functional Bowel Disease and Functional Abdominal Pain. Gastroenterology International 1992; 5: 75-91.
20. Clouse RE. Managing functional bowel disorders from the top down: lessons from a well-designed treatment trial. Gastroenterology 2003; 125: 249-53.
21. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999; 45(Suppl 2): II1-5.